Linear displacement isothermal amplification method and application thereof
US-2024368679-A1 · Nov 7, 2024 · US
US2016281153A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016281153-A1 |
| Application number | US-201615177149-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jun 8, 2016 |
| Priority date | Sep 16, 2013 |
| Publication date | Sep 29, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided herein are methods and kits for isothermal nucleic acid amplifications that use an oligocation-oligonucleotide conjugate primer for amplifying a target nucleic acid to generate amplicons. Isothermal DNA amplification methods that employ a strand displacing DNA polymerase and polyamine-oligonucleotide conjugate primer are also provided.
Opening claim text (preview).
1 . A kit for isothermal DNA amplification comprising: a DNA polymerase having strand displacement activity; and an oligocation-oligonucleotide conjugate primer, wherein the oligocation-oligonucleotide conjugate primer comprises an oligocation moiety covalently conjugated to the 5′ end of an oligonucleotide sequence. 2 . The kit of claim 1 , wherein the nucleotide sequence is a random oligonucleotide sequence. 3 . The kit of claim 1 , wherein the oligocation moiety comprises at least one spermine moiety. 4 . The kit of claim 1 , wherein the oligocation-oligonucleotide conjugate primer consists of oligocation-oligonucleotide conjugate sequences having structure IV, wherein integer value of n is 1 or 2. 5 . The kit of claim 1 , wherein the DNA polymerase is a Phi29 DNA polymerase. 6 . A kit for isothermal DNA amplification comprising: an oligocation-oligonucleotide conjugate primer; a DNA polymerase having a strand displacement activity; a dNTP mixture; and an oligocation-oligonucleotide conjugate primer, wherein the oligocation-oligonucleotide conjugate primer comprises an oligocation moiety covalently conjugated to the 5′ end of an oligonucleotide sequence and wherein the oligocation moiety comprises at least one lysine moiety. 7 . The kit of claim 6 , wherein the oligonucleotide sequence is a random oligonucleotide sequence or a partially constrained oligonucleotide sequence. 8 . The kit of claim 6 , wherein the oligonucleotide sequence comprises a nucleotide analogue. 9 . The kit of claim 6 , wherein the oligonucleotide sequence comprises a phosphorothioate linkage between a 3′ terminal nucleotide and a nucleotide that is adjacent to the 3′ terminal nucleotide. 10 . The kit of claim 9 , wherein the oligonucleotide sequence is NNNNN*N. 11 . The kit of claim 6 , wherein the oligocation-oligonucleotide conjugate primer comprises a random pentamer sequence or a random hexamer sequence. 12 . A kit for isothermal DNA amplification comprising: an oligocation-oligonucleotide conjugate primer; a DNA polymerase having a strand displacement activity; a dNTP mixture; and an oligocation-oligonucleotide conjugate primer, wherein the oligocation-oligonucleotide conjugate primer comprises an oligocation moiety covalently conjugated to the 5′ end of an oligonucleotide sequence and wherein the oligocation moiety comprises peptides having cationic side chains or a cationic polyamine. 13 . The kit of claim 12 , wherein the oligonucleotide sequence is a random oligonucleotide sequence or a partially constrained oligonucleotide sequence. 14 . The kit of claim 12 , wherein the oligonucleotide sequence comprises a nucleotide analogue. 15 . The kit of claim 12 , wherein the oligonucleotide sequence comprises a phosphorothioate linkage between a 3′ terminal nucleotide and a nucleotide that is adjacent to the 3′ terminal nucleotide. 16 . The kit of claim 15 , wherein the oligonucleotide sequence is NNNNN*N. 17 . The kit of claim 12 , wherein the oligocation-oligonucleotide conjugate primer comprises a random pentamer sequence or a random hexamer sequence. 18 . The kit of claim 12 , wherein the oligocation-oligonucleotide conjugate primer comprises a single spermine unit covalently conjugated to the 5′ terminal nucleotide of the oligonucleotide sequence. 19 . The kit of claim 12 , wherein the oligocation-oligonucleotide conjugate primer comprises two or three spermine moieties covalently coupled to the 5′ terminal nucleotide of the oligonucleotide sequence. 20 . The kit of claim 12 , wherein the DNA polymerase comprises a Phi29 DNA polymerase.
Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS] · CPC title
Polynucleotides, e.g. nucleic acids, oligoribonucleotides · CPC title
using modified primers or templates · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.